Sign In
Buy DCTH
$10.33
-0.200 (-1.90%)
At Close: Jun 03, 2026
Delcath Systems to Host Third Quarter 2023 Results Call
04:30pm, Monday, 06'th Nov 2023
NEW YORK , Nov. 6, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced tod
Delcath Systems to Participate at the H.C. Wainwright 25th Annual Investor Conference on September 12 and 13, 2023
04:00pm, Tuesday, 05'th Sep 2023
NEW YORK , Sept. 5, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will partic
Why Is Delcath Systems (DCTH) Stock Up 72% Today?
08:05am, Tuesday, 15'th Aug 2023
Delcath Systems (NASDAQ: DCTH ) stock is rocketing higher on Tuesday after getting an update from the FDA. This has the FDA approving HEPZATO KIT.
Delcath Systems: HEPZATO KIT Should Receive Approval On Aug 14 PDUFA
07:00am, Friday, 11'th Aug 2023
Delcath Systems recently passed FDA inspection without any manufacturing-related observations. The medical review for HEPZATO KIT has likely concluded successfully; FDA seems to have proposed a Black
Delcath Systems to File Its Second Quarter 2023 10-Q the Week of August 7 and Expects to Host a Conference Call the Following Week
08:30am, Thursday, 03'rd Aug 2023
NEW YORK , Aug. 3, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that
Delcath Systems Is Prepared For A U.S. Commercial Launch
03:00am, Thursday, 01'st Jun 2023
Delcath Systems is close to gaining FDA approval for its HEPZATO KIT, a minimally invasive liver cancer treatment. The company is well-funded and prepared for commercial operations in the U.S. and Eur
Delcath Systems (DCTH) Q1 2023 Earnings Call Transcript
10:13am, Friday, 12'th May 2023
Delcath Systems Inc. (NASDAQ:DCTH ) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Company Participants Gerard Michel - Chief Executive Officer Anthony Dias - Vice President, Finance Kevin M
Delcath Systems to Host First Quarter 2023 Results
08:30am, Wednesday, 03'rd May 2023
NEW YORK , May 3, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today
Delcath Systems, Inc. (DCTH) Q3 2022 Earnings Call Transcript
01:33pm, Tuesday, 08'th Nov 2022
Start Time: 08:30 January 1, 0000 9:00 AM ET Delcath Systems, Inc. (NASDAQ:DCTH ) Q3 2022 Earnings Conference Call November 08, 2022, 08:30 AM ET Company Participants Gerard Michel - CEO Anthony Dias
Delcath Systems to Participate at the H.C. Wainwright 24th Annual Global Investor Conference on September 12 and 13, 2022
04:15pm, Thursday, 01'st Sep 2022
NEW YORK , Sept. 1, 2022 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will particip
Delcath Systems, Inc. (DCTH) CEO Gerard Michel on Q2 2022 Results - Earnings Call Transcript
02:56pm, Monday, 08'th Aug 2022
Delcath Systems, Inc. (NASDAQ:DCTH ) Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants David Hoffman - General Counsel Gerard Michel - Chief Executive Officer Anthony Dia
Delcath Systems, Inc. (DCTH) Reports Q2 Loss, Lags Revenue Estimates
10:33am, Monday, 08'th Aug 2022
Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of -34.09% and 36.49%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Delcath Systems to Host Second Quarter 2022 Results
04:30pm, Wednesday, 27'th Jul 2022
NEW YORK , July 27, 2022 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced tod
What to Know About Buying Penny Stocks on June 7th?
07:00am, Tuesday, 07'th Jun 2022
Here's what you need to know about trading penny stocks on June 7th, 2022 The post What to Know About Buying Penny Stocks on June 7th? appeared first on Penny Stocks to Buy, Picks, News and Informatio
Delcath Systems Ltd. (DCTH) CEO Gerard Michel on Q1 2022 Results - Earnings Call Transcript
03:13pm, Tuesday, 10'th May 2022
Delcath Systems Ltd. (NASDAQ:DCTH ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants David Hoffman - General Counsel Gerard Michel - Chief Executive Officer Anthony Dias -
